Quanome Technologies M&A Deal with QAI Labs Ltd.
Quanome Technologies entered into a definitive stock purchase agreement to acquire a 5% equity stake in QAI Labs Ltd., a life sciences technology company developing an AI-enabled antibody discovery platform. In exchange for 31,579 newly issued shares of QAI Labs, Quanome will issue 6,541,236 shares of its own common stock to the seller. The transaction advances Quanome's strategic pillar of applying quantum science and AI to molecular discovery.
- Counterparty
- QAI Labs Ltd.